ACM
CL icon

Alethea Capital Management’s Colgate-Palmolive CL Stock Holding History

Alethea Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,232
Closed -$499K – 63
2022
Q2 		$499K Buy
+6,232
New +$487K 0.62% 14
2021
Q3 		– Sell
-8,471
Closed -$689K – 87
2021
Q2 		$689K Buy
+8,471
New +$693K 0.43% 27
2020
Q3 		– Sell
-6,706
Closed -$491K – 75
2020
Q2 		$491K Buy
+6,706
New +$476K 0.29% 41
2017
Q4 		– Sell
-10,488
Closed -$764K – 81
2017
Q3 		$764K Buy
+10,488
New +$756K 0.9% 32

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alethea Capital Management's CL Position: Q3 2022 in Review

Alethea Capital Management sold out of Colgate-Palmolive (CL) in Q3 2022, closing a stake of 6,232 shares — an estimated $499K sold.

Alethea Capital Management first reported a position in CL in Q3 2017 and held it in 4 quarters. The position peaked at $764K in Q3 2017. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • Alethea Capital Management reported no remaining Colgate-Palmolive position as of Q3 2022 after selling out during the quarter.
  • Alethea Capital Management sold 6,232 Colgate-Palmolive shares in Q3 2022, an estimated $499K.
  • Alethea Capital Management first reported a position in Colgate-Palmolive in Q3 2017 and held it in 4 quarters.
  • Alethea Capital Management's Colgate-Palmolive position peaked at $764K in Q3 2017.
  • 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on Alethea Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.